A Comparison of mXELIRI Regimen and FOLFIRI Combined Bevacizumab Regimen as First-line Chemotherapy Regimen for Metastatic Colorectal Cancer
Clinical trial NCT04247984 · COMPLETED
Trial details
- NCT number
- NCT04247984
- Sponsor
- Chinese Academy of Medical Sciences
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-01
- Primary completion
- 2021-04-01
- Enrollment
- 264
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.